Cholesta-6,22,24-trien,4,4-dimethyl for COVID-19

 Cholesta-6,22,24-trien,4,4-dimethyl has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed cholesta-6,22,24-trien,4,4-dimethyl in detail.
Ran et al., Scutellaria barbata D. Don extracts alleviate SARS-CoV-2 induced acute lung injury by inhibiting virus replication and bi-directional immune modulation, Virologica Sinica, doi:10.1016/j.virs.2025.04.004